News

OctoPlus provides formulation development and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. In addition OctoPlus offers its clients drug delivery technologies for the development of

According to Progenika Biopharma, the diagnostic test rapidly diagnoses patients with complete and partial lipoprotein lipase deficiency (LPLD) and has been developed under an agreement with Amsterdam Molecular

Novartis said that the CHMP recommendation will serve as the basis for the European Commission making its licensing decision of the Aflunov product. Based on the CHMP approval,

Zibotentan is a novel once daily tablet and works by blocking the endothelin pathway. The Phase III study assessed Zibotentan 10mg added to standard of care treatment in

Bayer claimed that Beyaz is the first OC approved to raise folate levels, in women who choose an OC for birth control, for the purpose of reducing the

According to the CHMP, the benefits from using the drug to treat MS did not justify its risks. Recently, Merck’s MS pill got Austrailian and Russian approval and

In the Phase 1 trial Stedivaze was administered to patients with mild to moderate asthma as a single IV bolus, the same as utilized in the ongoing Phase

NextPharma claims that its Belgian site, Braine-l’Alleud, has extensive know how in aseptic production and packaging including the manufacture of cytotoxic products (lyophilization and solutions) gained over more

Pfizer has initiated the recall as a precautionary step after finding a potential for a leak of the components contained in the wrap, which could cause skin injury